Type II Diabetes in Subjects BMI 27 to 32

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08907Canagliflozin4Completed1
DB09038Empagliflozin4Completed1
DB08882Linagliptin4Completed1
DB06655Liraglutide4Completed1
DB01083Orlistat4Completed1
DB01261Sitagliptin4Completed1